Are you experiencing hand or wrist pain? We can offer nonsurgical solutions to treat many hand and wrist conditions.
Wrist and Hand biologic/regenerative medicine injections can be performed to treat a variety of conditions including, various tendinitis’, arthritis and ligament injuries under ultrasound guidance. More research is continually being conducted to study the benefits of these treatments in many conditions such as:
Carpal tunnel
Osteoarthritis
Various Tendinitis’
Post Surgical Enhanced Healing
Twelve randomized controlled trials with 749 patients (817 hands) were included. The results of this study suggested that PRP injection was the most likely to relieve symptoms, improve functions and alleviate pain
In CTS, PRP was a better treatment alternative with respect to pain and functional outcome. In addition, it was associated well with improved neurophysiological values than those observed after corticosteroid injection.
PRP and CARPAL TUNNEL SYNDROME
What research says:
Twelve randomized controlled trials with 749 patients (817 hands) were included. The results of this study suggested that PRP injection was the most likely to relieve symptoms, improve functions and alleviate pain, with the SUCRA being 91.5%, 92.7%, and 80.8%, respectively, followed by D5W injection (74.4%, 72.2%, 72.1%), and corticosteroid injection (33.7%, 31.9%, 46.2%). The injection of three drugs was significantly better than that of a placebo.
PRP and DEQUERVAINS TENOSYNOVITIS
What research says:
Platelet-Rich Plasma Injection and Corticosteroid Injection for the Treatment of de Quervain's Tenosynovitis. Both the modalities are equally effective in the management of DQTSV remittance. PRP is equally effective as corticosteroid in reducing symptoms of first dorsal compartment stenosing tenosynovitis. PRP may have a lower complication profile, however, this benefit should be weighed against the slight increase in cost and time of PRP preparation and injection.
PRP and (THUMB) BASAL JOINT OSTEOARTHRITIS
What research says:
despite the promising result for platelet-rich plasma, the evidence quality was limited to two studies only justifying the need for further and larger methodologically robust trials investigating corticosteroids, hyaluronic acid and platelet-rich plasma vs each other and placebo.